MMS Named Michigan Top Workplace for the Second Consecutive Year

CANTON, Mich.–(BUSINESS WIRE)–#biotech–MMS Holdings, a data-focused contract research organization (CRO), has been named a 2022 award winner of the Michigan Top Workplaces by the Detroit Free Press Top Workplaces. This is the second year that MMS has been recognized with this honor. This award is based on feedback from a confidential survey sent out to … [Read more…]

Data Across Daiichi Sankyo DXd ADC Portfolio at 2022 SABCS Demonstrates Bold Progress in Advancing Treatment for Patients with Breast Cancer

Survival data from DESTINY-Breast03 and DESTINY-Breast02 phase 3 trials in patients with HER2 positive metastatic breast cancer further confirms efficacy of ENHERTU First presentation of datopotamab deruxtecan results in patients with HR positive, HER2 negative metastatic breast cancer shows promising clinical activity Annual R&D Day following SABCS to provide updates across Daiichi Sankyo R&D portfolio … [Read more…]

Leading Healthcare Organizations Choose Qualtrics to Deliver Ease and Empathy to Patients and Caregivers

PROVO, Utah & SEATTLE–(BUSINESS WIRE)–Qualtrics (Nasdaq: XM), the leader and creator of the experience management category, today announced that dozens of leading healthcare organizations, including Ascension and Intermountain Healthcare, selected Qualtrics solutions in the third quarter of 2022. By adopting technology to better understand patients, caregivers and staff – not just their experience in receiving … [Read more…]

Swing Therapeutics Announces Positive Results from Studies of Stanza, a Digital Therapeutic for Fibromyalgia Treatment

Abstracts presented at the American College of Rheumatology (ACR) annual meeting demonstrate exciting results for digital therapeutics Swing Care launches in Texas to focus on virtual treatment of fibromyalgia patients SAN FRANCISCO–(BUSINESS WIRE)–Swing Therapeutics, a digital therapeutics company developing evidence-backed treatments for autoimmune and chronic pain conditions, today announced the presentation of research supporting the … [Read more…]

Graphite Bio Announces Participation in Evercore ISI 5th Annual HealthCONx Conference

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Graphite Bio, Inc. (Nasdaq: GRPH), a clinical-stage, next-generation gene editing company harnessing the power of high-efficiency precision gene repair to develop therapies with the potential to treat or cure serious diseases, today announced that members of the management team will participate in a fireside chat at the Evercore ISI 5th Annual … [Read more…]

Flare Therapeutics to Present at Piper Sandler 34th Annual Healthcare Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Flare Therapeutics, a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases, today announced that Daphne Karydas, Chief Operating Officer and Chief Financial Officer of Flare Therapeutics, will present a company overview at 9:30 a.m. ET on Thursday, December 1, 2022 at the Piper Sandler 34th Annual Healthcare … [Read more…]

Healiva® Acquires Critical Cell Therapy Manufacturing Assets From B. Braun

The acquisition will accelerate the launch of Healiva’s personalised skin regeneration therapy, EpiDex® LUGANO, Switzerland–(BUSINESS WIRE)–#Burdenofwounds—Healiva®, a patient-centric company delivering life-enhancing precision medicine for patients with chronic and acute wounds, announced today the acquisition of critical manufacturing assets from B. Braun Medical AG Switzerland, an affiliate of German medical and pharmaceutical device company, B. Braun … [Read more…]

Thermo Fisher Scientific to Present at Evercore ISI HealthCONx Conference

WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022, at 10:30 a.m. (EST). You can access the webcast of the presentation via the Investors section of … [Read more…]

Pear Therapeutics to Participate in Evercore ISI 5th Annual HealthCONx Conference

BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will participate in the Evercore ISI 5th Annual HealthCONx Conference on Wednesday, November 30, 2022. Corey McCann, M.D., Ph.D., President and CEO, will participate in a virtual fireside chat at 12:10 p.m. … [Read more…]